IDiyas

For the Inventor, By the Inventor

Madison, WI, United States of America

Warren D Woessner

USPTO Granted Patents = 20

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 97(Granted Patents)


Company Filing History:

goldMedal19 out of 504 
 
Miles Laboratories, Inc.
 patents
silverMedal1 out of 539 
 
Miles Inc.
 patents

Years Active: 1976-1989

Loading Chart...
20 patents (USPTO):Explore Patents
1. 4833157 - Methods of inhibitng gastric secretion with prostaglandin derivatives (1989-05-23),
2. 4415592 - 15-Deoxy-16-hydroxy prostaglandins for producing bronchodilation (1983-11-15),
3. 4336404 - 1-Acyloxy-15-deoxy-16-hydroxy-analogs of prostaglandin E.sub.1 (1982-06-22),
4. 4331688 - Therapeutic method for inhibiting gastric secretion by administration of (1982-05-25),
5. 4275224 - 15-Deoxy-16-hydroxy prostaglandins (1981-06-23),
6. 4206127 - 5,6-Dihydro analogues of prostaglandin I.sub.2 (1980-06-03),
7. 4171331 - 1 And 2-substituted analogues of certain prostaglandins (1979-10-16),
8. 4149017 - Intermediates for the preparation of bicycloalkyl derivatives of (1979-04-10),
9. 4138583 - Cycloalkenyl analogues of prostaglandin F (1979-02-06),
10. 4138582 - Cycloalkenyl analogues of prostaglandin A (1979-02-06),
11. 4132738 - Preparation of 15-deoxy-16-hydroxyprostaglandins (1979-01-02),
12. 4127612 - 19-Hydroxy PGE.sub.1 carbinol analogues (1978-11-28),
13. 4115453 - Bicycloalkyl derivatives of prostaglandins PGE.sub.1 alcohols (1978-09-19),
14. 4115438 - Bicycloalkyl derivatives of prostaglandins 11-deoxy-PGE.sub.2 acids and (1978-09-19),
15. 4108892 - Bicycloalkyl derivatives of prostaglandins: 11-deoxy-PGE.sub.1 acids and (1978-08-22),

Title: Warren D Woessner: Pioneering Inventor in Madison, WI

Introduction:

Warren D Woessner, a dedicated inventor based in Madison, WI, is renowned for his significant contributions to the field of medical innovations. With an impressive portfolio of 20 patents, Woessner's inventive spirit and expertise have revolutionized healthcare solutions.

Latest Patents:

1. Methods of inhibiting gastric secretion with prostaglandin derivatives: Woessner's patented therapeutic method focuses on inhibiting gastric secretion in individuals where necessary. By administering specific derivatives of 15-deoxy-16-hydroxy-prostaglandin E1 esters, this innovative approach enhances treatment outcomes for gastric-related issues.

2. 15-Deoxy-16-hydroxy prostaglandins for producing bronchodilation: Woessner's second patent involves analogues of PGE1 designed to induce bronchodilation effectively. These compounds not only promote bronchodilation but also reduce gastric secretion in vivo, showcasing Woessner's multi-faceted contributions to medical advancements.

Career Highlights:

Having worked at renowned companies such as Miles Laboratories, Inc. and Miles Inc., Woessner has honed his skills and expertise over the years. His tenure at these esteemed organizations has provided him with valuable experience and industry knowledge, shaping him into the esteemed inventor he is today.

Collaborations:

Throughout his career, Warren D Woessner has collaborated with esteemed professionals in the field. Notable coworkers include William G Biddlecom and Harold C Kluender, with whom Woessner has jointly worked on innovative projects, further enhancing his inventive capabilities through fruitful collaborations.

Conclusion:

Warren D Woessner's innovative contributions to the medical field through his patents and career achievements underscore his dedication to advancing healthcare solutions. His inventive mindset and collaborative efforts have solidified his position as a pioneering inventor, shaping the landscape of medical innovations for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…